Exocrine Pancreatic Insufficiency Market to 2027 - Global Analysis and Forecasts By Type (Imaging and Sample Test), End User (Hospitals, Diagnostic Laboratories and Others) and Geography
Report Code: TIPMD00002573 No. of Pages: 150 Category: Medical Device Status: Upcoming
Exocrine pancreatic insufficiency (EPI) is characterized as deficiency in exocrine pancreatic enzymes that result into an inability to maintain normal digestion. EPI may be caused due to cystic fibrosis (CF) or chronic pancreatitis. The symptoms for this are weight loss, greasy and foul-smelling stools, stomach cramps, and diarrhea. The disorder is diagnosed with the help of blood test, fecal test or by the mode of imaging.
The exocrine pancreatic insufficiency market is likely to anticipate grow with a significant rate in the forecast years, owing to driving factors such as, rise in the prevalence of gastrointestinal disorders, ulcerative colitis, and small intestinal bacterial growth among others. In addition, increasing prevalence of the cystic fibrosis, pancreatic cancer, diabetes are likely to grow the market in the forecast years. The market is likely to seek various opportunities to develop easy test and innovative products to treat the exocrine pancreatic insufficiency.
The "Global Exocrine Pancreatic Insufficiency Market Analysis To 2027" is a specialized and in-depth study of the medical device industry with a focus on the exocrine pancreatic insufficiency market trend. The report aims to provide an overview of global exocrine pancreatic insufficiency market with detailed market segmentation by type, end user and geography. The global exocrine pancreatic insufficiency market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the exocrine pancreatic insufficiency market.
The global exocrine pancreatic insufficiency market is segmented on the basis of type and end user. On the basis type segment includes imaging and sample test. The imaging segment is further divided into sub-segments such as CT scanning, endoscopic ultra-sonography (EUS), magnetic resonance imaging (MRI) and others. Similarly, the sample test is further divided into blood test, fecal test and pancreatic function test. On the basis of the end user the segment is classified as hospitals, diagnostic laboratories and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global exocrine pancreatic insufficiency market based on type, end user and geography. It also provides market size and forecast till 2027 for overall exocrine pancreatic insufficiency market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the exocrine pancreatic insufficiency market in the coming years, owing to factors such as, rise in the incidences of the bacterial infection, rise in the prevalence of the exocrine pancreatic insufficiency and more. The Europe and Asia Pacific market is anticipated to hold large market share following the North America. The rise in the geriatric population across these regions are likely to contribute to the significant growth rate for the market.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key exocrine pancreatic insufficiency market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medtronic, General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, Canon Medical Systems, USA, ThermoFisher Scientific Inc.,ScheBo Biotech AG, Hologic Inc., Immunostics, Inc. and Biohit Oyj.
The exocrine pancreatic insufficiency market is likely to anticipate grow with a significant rate in the forecast years, owing to driving factors such as, rise in the prevalence of gastrointestinal disorders, ulcerative colitis, and small intestinal bacterial growth among others. In addition, increasing prevalence of the cystic fibrosis, pancreatic cancer, diabetes are likely to grow the market in the forecast years. The market is likely to seek various opportunities to develop easy test and innovative products to treat the exocrine pancreatic insufficiency.
The "Global Exocrine Pancreatic Insufficiency Market Analysis To 2027" is a specialized and in-depth study of the medical device industry with a focus on the exocrine pancreatic insufficiency market trend. The report aims to provide an overview of global exocrine pancreatic insufficiency market with detailed market segmentation by type, end user and geography. The global exocrine pancreatic insufficiency market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the exocrine pancreatic insufficiency market.
The global exocrine pancreatic insufficiency market is segmented on the basis of type and end user. On the basis type segment includes imaging and sample test. The imaging segment is further divided into sub-segments such as CT scanning, endoscopic ultra-sonography (EUS), magnetic resonance imaging (MRI) and others. Similarly, the sample test is further divided into blood test, fecal test and pancreatic function test. On the basis of the end user the segment is classified as hospitals, diagnostic laboratories and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global exocrine pancreatic insufficiency market based on type, end user and geography. It also provides market size and forecast till 2027 for overall exocrine pancreatic insufficiency market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the exocrine pancreatic insufficiency market in the coming years, owing to factors such as, rise in the incidences of the bacterial infection, rise in the prevalence of the exocrine pancreatic insufficiency and more. The Europe and Asia Pacific market is anticipated to hold large market share following the North America. The rise in the geriatric population across these regions are likely to contribute to the significant growth rate for the market.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key exocrine pancreatic insufficiency market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medtronic, General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, Canon Medical Systems, USA, ThermoFisher Scientific Inc.,ScheBo Biotech AG, Hologic Inc., Immunostics, Inc. and Biohit Oyj.
Table of Contents
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. EXOCRINE PANCREATIC INSUFFICIENCY MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Exocrine Pancreatic Insufficiency Market - By Type
3.2.2. Exocrine Pancreatic Insufficiency Market - By End User
3.2.3. Exocrine Pancreatic Insufficiency Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. EXOCRINE PANCREATIC INSUFFICIENCY MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - BY TYPE
5.1. OVERVIEW
5.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
5.3. IMAGING MARKET
5.3.1. Overview
5.3.2. Imaging Market Revenue Forecasts and Analysis (US$ Mn)
5.3.3. Computerized Tomography Scan Market
5.3.3.1. Overview
5.3.3.2. Computerized Tomography Scan Market Revenue Forecasts and Analysis (US$ Mn)
5.3.4. Magnetic Resonance Imaging Market
5.3.4.1. Overview
5.3.4.2. Magnetic Resonance Imaging Market Revenue Forecasts and Analysis (US$ Mn)
5.3.5. Endoscopic Ultrasonography Market
5.3.5.1. Overview
5.3.5.2. Endoscopic Ultrasonography Market Revenue Forecasts and Analysis (US$ Mn)
5.3.6. Others Market
5.3.6.1. Overview
5.3.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
5.4. SAMPLE TEST MARKET
5.4.1. Overview
5.4.2. Sample Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.3. Blood Test Market
5.4.3.1. Overview
5.4.3.2. Blood Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.4. Faecal Test Market
5.4.4.1. Overview
5.4.4.2. Faecal Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.5. Pancreatic Function Test Market
5.4.5.1. Overview
5.4.5.2. Pancreatic Function Test Market Revenue Forecasts and Analysis (US$ Mn)
6. EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
6.1. OVERVIEW
6.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. HOSPITALS MARKET
6.3.1. Overview
6.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
6.4. DIAGNOSTIC LABORATORIES MARKET
6.4.1. Overview
6.4.2. Diagnostic Laboratories Market Revenue Forecasts and Analysis (US$ Mn)
6.5. OTHERS MARKET
6.5.1. Overview
6.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
7. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
7.1. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
7.2. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
7.3. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
7.3.1. North America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.3.2. North America Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.4. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
7.5. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
7.6. US MARKET OVERVIEW
7.6.1. US Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.6.1.1. US Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.6.1.2. US Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.6.2. US Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
7.7. CANADA MARKET OVERVIEW
7.7.1. Canada Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.7.1.1. Canada Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.7.1.2. Canada Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.7.2. Canada Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
7.8. MEXICO MARKET OVERVIEW
7.8.1. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.8.1.1. Mexico Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.8.1.2. Mexico Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.8.2. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Application (US$ Mn)
7.8.3. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
8.2. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
8.3.1. Europe Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.3.2. Europe Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.4. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.5. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. UK MARKET OVERVIEW
8.6.1. UK Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.6.1.1. UK Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.1.2. UK Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.2. UK Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.7. GERMANY MARKET OVERVIEW
8.7.1. Germany Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.7.1.1. Germany Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.1.2. Germany Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.2. Germany Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.8. FRANCE MARKET OVERVIEW
8.8.1. France Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.8.1.1. France Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.1.2. France Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.2. France Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
9.2. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.3.1. Asia Pacific Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.3.2. Asia Pacific Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. CHINA MARKET OVERVIEW
9.6.1. China Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.1.1. China Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.1.2. China Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.2. China Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. JAPAN MARKET OVERVIEW
9.7.1. Japan Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.1.1. Japan Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.1.2. Japan Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2. Japan Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. INDIA MARKET OVERVIEW
9.8.1. India Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.1.1. India Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.1.2. India Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2. India Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
10.2. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.3.1. Middle East and Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.3.2. Middle East and Africa Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. UAE MARKET OVERVIEW
10.6.1. UAE Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.1.1. UAE Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.1.2. UAE Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.2. UAE Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. SAUDI ARABIA MARKET OVERVIEW
10.7.1. Saudi Arabia Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.1.1. Saudi Arabia Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.1.2. Saudi Arabia Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.2. Saudi Arabia Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. SOUTH AFRICA MARKET OVERVIEW
10.8.1. South Africa Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.1.1. South Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.1.2. South Africa Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2. South Africa Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
11.2. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.3.1. South and Central America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.3.2. South and Central America Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. BRAZIL MARKET OVERVIEW
11.6.1. Brazil Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.1.1. Brazil Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.1.2. Brazil Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2. Brazil Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. INDUSTRY LANDSCAPE
12.1. ORGANIC GROWTH STRATEGIES
12.1.1. New Product Launches
12.1.2. Marketing & Promotional Activities
12.2. INORGANIC GROWTH STRATEGIES
12.2.1. Partnerships, Collaborations, and Joint Ventures
12.2.2. Mergers & Acquisitions
13. EXOCRINE PANCREATIC INSUFFICIENCY MARKET, KEY COMPANY PROFILES
13.1. MEDTRONIC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GENERAL ELECTRIC COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. KONINKLIJKE PHILIPS N.V.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Type/Type Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SIEMENS HEALTHCARE GMBH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CANON MEDICAL SYSTEMS, USA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. THERMOFISHER SCIENTIFIC INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SCHEBO BIOTECH AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HOLOGIC INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. IMMUNOSTICS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIOHIT OYJ
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. EXOCRINE PANCREATIC INSUFFICIENCY MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Exocrine Pancreatic Insufficiency Market - By Type
3.2.2. Exocrine Pancreatic Insufficiency Market - By End User
3.2.3. Exocrine Pancreatic Insufficiency Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. EXOCRINE PANCREATIC INSUFFICIENCY MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - BY TYPE
5.1. OVERVIEW
5.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
5.3. IMAGING MARKET
5.3.1. Overview
5.3.2. Imaging Market Revenue Forecasts and Analysis (US$ Mn)
5.3.3. Computerized Tomography Scan Market
5.3.3.1. Overview
5.3.3.2. Computerized Tomography Scan Market Revenue Forecasts and Analysis (US$ Mn)
5.3.4. Magnetic Resonance Imaging Market
5.3.4.1. Overview
5.3.4.2. Magnetic Resonance Imaging Market Revenue Forecasts and Analysis (US$ Mn)
5.3.5. Endoscopic Ultrasonography Market
5.3.5.1. Overview
5.3.5.2. Endoscopic Ultrasonography Market Revenue Forecasts and Analysis (US$ Mn)
5.3.6. Others Market
5.3.6.1. Overview
5.3.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
5.4. SAMPLE TEST MARKET
5.4.1. Overview
5.4.2. Sample Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.3. Blood Test Market
5.4.3.1. Overview
5.4.3.2. Blood Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.4. Faecal Test Market
5.4.4.1. Overview
5.4.4.2. Faecal Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.5. Pancreatic Function Test Market
5.4.5.1. Overview
5.4.5.2. Pancreatic Function Test Market Revenue Forecasts and Analysis (US$ Mn)
6. EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
6.1. OVERVIEW
6.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. HOSPITALS MARKET
6.3.1. Overview
6.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
6.4. DIAGNOSTIC LABORATORIES MARKET
6.4.1. Overview
6.4.2. Diagnostic Laboratories Market Revenue Forecasts and Analysis (US$ Mn)
6.5. OTHERS MARKET
6.5.1. Overview
6.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
7. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
7.1. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
7.2. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
7.3. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
7.3.1. North America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.3.2. North America Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.4. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
7.5. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
7.6. US MARKET OVERVIEW
7.6.1. US Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.6.1.1. US Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.6.1.2. US Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.6.2. US Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
7.7. CANADA MARKET OVERVIEW
7.7.1. Canada Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.7.1.1. Canada Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.7.1.2. Canada Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.7.2. Canada Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
7.8. MEXICO MARKET OVERVIEW
7.8.1. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.8.1.1. Mexico Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.8.1.2. Mexico Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.8.2. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Application (US$ Mn)
7.8.3. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
8.2. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
8.3.1. Europe Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.3.2. Europe Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.4. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.5. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. UK MARKET OVERVIEW
8.6.1. UK Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.6.1.1. UK Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.1.2. UK Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.2. UK Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.7. GERMANY MARKET OVERVIEW
8.7.1. Germany Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.7.1.1. Germany Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.1.2. Germany Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.2. Germany Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.8. FRANCE MARKET OVERVIEW
8.8.1. France Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.8.1.1. France Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.1.2. France Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.2. France Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
9.2. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.3.1. Asia Pacific Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.3.2. Asia Pacific Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. CHINA MARKET OVERVIEW
9.6.1. China Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.1.1. China Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.1.2. China Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.2. China Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. JAPAN MARKET OVERVIEW
9.7.1. Japan Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.1.1. Japan Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.1.2. Japan Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2. Japan Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. INDIA MARKET OVERVIEW
9.8.1. India Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.1.1. India Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.1.2. India Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2. India Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
10.2. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.3.1. Middle East and Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.3.2. Middle East and Africa Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. UAE MARKET OVERVIEW
10.6.1. UAE Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.1.1. UAE Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.1.2. UAE Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.2. UAE Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. SAUDI ARABIA MARKET OVERVIEW
10.7.1. Saudi Arabia Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.1.1. Saudi Arabia Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.1.2. Saudi Arabia Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.2. Saudi Arabia Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. SOUTH AFRICA MARKET OVERVIEW
10.8.1. South Africa Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.1.1. South Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.1.2. South Africa Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2. South Africa Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
11.2. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.3.1. South and Central America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.3.2. South and Central America Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. BRAZIL MARKET OVERVIEW
11.6.1. Brazil Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.1.1. Brazil Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.1.2. Brazil Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2. Brazil Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. INDUSTRY LANDSCAPE
12.1. ORGANIC GROWTH STRATEGIES
12.1.1. New Product Launches
12.1.2. Marketing & Promotional Activities
12.2. INORGANIC GROWTH STRATEGIES
12.2.1. Partnerships, Collaborations, and Joint Ventures
12.2.2. Mergers & Acquisitions
13. EXOCRINE PANCREATIC INSUFFICIENCY MARKET, KEY COMPANY PROFILES
13.1. MEDTRONIC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GENERAL ELECTRIC COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. KONINKLIJKE PHILIPS N.V.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Type/Type Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SIEMENS HEALTHCARE GMBH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CANON MEDICAL SYSTEMS, USA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. THERMOFISHER SCIENTIFIC INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SCHEBO BIOTECH AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HOLOGIC INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. IMMUNOSTICS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIOHIT OYJ
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
The List of Companies
1. Medtronic
2. General Electric Company
3. Koninklijke Philips N.V.
4. Siemens Healthcare GmbH
5. Canon Medical Systems, USA
6. ThermoFisher Scientific Inc.
7. ScheBo Biotech AG
8. Hologic Inc.
9. Immunostics, Inc.
10. Biohit Oyj
1. Medtronic
2. General Electric Company
3. Koninklijke Philips N.V.
4. Siemens Healthcare GmbH
5. Canon Medical Systems, USA
6. ThermoFisher Scientific Inc.
7. ScheBo Biotech AG
8. Hologic Inc.
9. Immunostics, Inc.
10. Biohit Oyj